IMOVANE

This brand name is authorized in Australia, Brazil, Canada, Estonia, Finland, France, Hong Kong, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug IMOVANE contains one active pharmaceutical ingredient (API):

1 Zopiclone UNII 03A5ORL08Q - ZOPICLONE

Zopiclone is a hypnotic agent belonging to the cyclopyrrolone class of psychotherapeutic agents. It rapidly initiates and sustains sleep without reduction of total REM sleep and with preservation of slow wave sleep. Negligible residual effects are seen the following morning. Its pharmacological properties include hypnotic, sedative, anxiolytic, anticonvulsant and muscle-relaxant actions. Read about Zopiclone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMOVANE Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CF01	Zopiclone	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CF Benzodiazepine related drugs
Discover more medicines within N05CF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4522B
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502806201116315, 576720080085217
Country: CA	Health Products and Food Branch	Identifier(s): 01926799, 02216167
Country: EE	Ravimiamet	Identifier(s): 1068083, 1764480, 1767304, 1839506, 1846313, 1846324, 1846335, 1888465, 1888476
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 085852, 085860, 087304, 087312, 087320
Country: FR	Base de données publique des médicaments	Identifier(s): 61435939, 68508795
Country: HK	Department of Health Drug Office	Identifier(s): 31180
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3329, 9348
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014326, 1086398, 1092751, 1092752, 1092753
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 24732
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4471
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100000882, 100322634, 100335654, 100344481, 100345635, 100355250, 100357408, 100358773, 100367186, 100367447, 100367720, 100368435, 100416482, 100445868
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64484001, W64484002
Country: SG	Health Sciences Authority	Identifier(s): 05047P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699586010231, 8699586010279
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/2.2/0104